SynuSight Biotech (SynuSight), a clinical-stage biotech company focused on innovative pipeline development for neurodegenerative diseases, today announced the publication of a collaborative study in ...

Researchers in the lab of Cancer Center at Illinois (CCIL) member Xing Wang have discovered the influential role of ...

Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC ...

When thinking of the immune system, most people imagine white blood cells putting up a fight against invading germs in the ...

Company will highlight new and recently published data for stem cell therapy laromsestrocel Focus on potential partnership and strategic ...

Stretched into a single line, the DNA packed inside one human cell would reach roughly two meters, yet it folds into a ...

Damon Runyon has awarded Quantitative Biology Fellowships to three outstanding young scientists applying computational approaches to persistent biological questions. Their projects will use machine ...

TOR', a protein in our body, becomes excessively activated in cancer cells, promoting cell growth and metastasis. Korean researchers have discovered for the first time in the world that '13-HODE'—a ...

In response to stress or damage, cells undergo senescence and stop dividing. However, if senescent cells accumulate in tissues over the long term, chronic inflammation occurs and the risk of cancer ...

Researchers have developed a type of peptides that can enter cells and block protein interactions considered difficult to ...

Phase 3 AD trial: 85% of patients enrolled; full enrollment on track in summer 2026PD open-label extension (OLE) study: 40% of patients enrolled; full enrollment on track in fourth quarter 2026New Dru ...

DECNUPAZ is the first and only antibody-drug conjugate (ADC) approved for blastic plasmacytoid dendritic cell neoplasm (BPDCN) that is initiated in an outpatient ...